APEPTICO is a biotech company developing new peptide-based medicinal drugs for the treatment of severe and chronic diseases.
APEPTICO is an innovative biotech company that develops new peptide-based medicinal drugs for the therapeutic and prophylactic treatment of severe and chronic diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 5, 2010 | Series A | $3.95M | 1 | BioScience Ventures Group | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BioScience Ventures Group | Yes | Series A |